Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA ...
9don MSN
US FDA commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost
By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday ...
By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug ...
The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.
Six days after a senior FDA official sent a sweeping internal email claiming that COVID-19 vaccines had caused the deaths of "at least 10 children," 12 former FDA commissioners released an ...
Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at least 10 children," 12 former FDA commissioners released an extraordinary ...
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA ...
Pfizer CEO Albert Bourla on Monday flagged issues with the leadership of the U. Food and Drug Administration's vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results